UK Lysosomal Storage Disorders Market Analysis

$3,500.00$7,500.00

  • Type: Rare Disease Area
  • Published : April 2021
  • Region: Europe
  • Country: UK
  • Report ID : 2579

  • Format: PPT, PDF

UK Lysosomal Storage Disorders Therapeutics Market: Segmented by Treatment Type, and End Users – Size, Share, Impact, Growth, Trends, and Forecasts (2020 – 2028)

Published Date: June 2021

 

Clear
SKU: 2579 Categories: ,

Report Overview

The UK Lysosomal Storage Disorders Therapeutics market size stood at around USD xx billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

LSDs usually is caused by a deficiency of a single lysosomal enzyme or protein, which results in a build-up of lipid or sugar in the lysosome. There are many lysosomal enzymes and they each work in sequence with each other to break down lipids and sugars into simpler forms for removal from the cell. A deficiency in the function of one enzyme means that the process of breaking down and recycling lipids and sugars stops, and they remain stored in the lysosomes of each cell. This affects normal cell function.

There are nearly 50 of these disorders altogether, and they may affect different parts of the body, including the skeleton, brain, skin, heart, and central nervous system. According to NHS Foundation Trust, the incidence is approximately 1 in 7,000 births.  Although affected children usually appear normal at birth, each disorder progressively develops symptoms, which can include bone and skeletal deformity, visual and hearing problems, enlarged head and tongue, coarse hair, developmental delays, and reduction over time of the mental function. One of the main objectives of the service is to increase the benefits of treatment for patients with LSDs with particular reference to the use of enzyme replacement therapy.

The types of lysosomal storage disorders that occur most often in babies and children include Gaucher Disease (Types I, II, and III), Batten Disease, Cystinosis, Fabry Disease, Pompe Disease, Aspartylglucosaminuria, Niemann Pick Disease, and Tay Sachs Disease.

Market Growth Drivers

An increasing diagnosis rate due to growing public awareness and financial incentives for orphan drug development to recover R&D costs is the primary factor fuelling the growth of the LSD therapeutics market. Also, an increasing focus of major biopharmaceutical companies on the research and development of drugs for the treatment of lysosomal storage disorders is expected to boost the LSD therapeutics market growth during the forecast period.

Moreover, the number of treatment options currently in the pipeline is further expected to bolster the revenue growth of the LSD therapeutics market over the forecast period. The advent of therapies targeting neuropathic manifestations by crossing the blood-brain barrier (BBB) and therapies that overcome immune response and have better tissue selectivity has also been anticipated to fuel the LSD therapeutics market growth in the upcoming years.

Market Restraints

However, the UK LSD therapeutics market also faces a few restraints that include heterogeneity of the disease leading to underdiagnoses of lysosomal storage disorders, lack of treatment options, expensive drugs, change in payer policies, lack of proper training and knowledge, nature of the disease, and concerns in diagnosis. The restraints can be overcome by the drugs that aid in improving the lifespan and quality of life for the patients.

TABLE OF CONTENTS

1. UK Lysosomal Storage Disorders Therapeutics Market Overview……………
A. Market Size
2. Market Growth Drivers and Restraints……………………………………….…
Market Growth Drivers
A. Increasing Diagnosis Rate
B. Growing Public Awareness
C. Financial Incentives for Orphan Drug Development
D. Increase in R&D Expenditure & Intensive Research on Novel Treatment
E. Rising Incidence and Prevalence of Major Lysosomal Storage Disorders
Market Restraints
A. Lack of Treatment Options
B. Expensive Drugs
C. Lack of Experienced Professionals
D. Change in Payer Policies
3. Major Types of Lysosomal Storage Disorders……………………………….
A. Gaucher Disease
B. Fabry Disease
C. Pompe Disease
D. Mucopolysaccharidosis
E. Batten Disease
F. Niemann Pick Disease
G. Tay Sachs Disease
H. Others
4. Lysosomal Storage Disorders Therapeutics Market Segmentation………………
A. By Treatment Type
I. Enzyme Replacement Therapy (ERT)
II. Stem Cell Therapy (SCT)
III. Substrate Reduction Therapy (SRT)
IV. Other Therapies
B. By End Users
I. Hospitals
II. Clinics
III. Diagnostics Centres
IV. Academic and Research Organisations
V. Others
5. Lysosomal Storage Disorders Major Drugs Market Share……………………
A. Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape…………………………………………………………………
A. Major Players
B. Products in Pipeline
7. Key Company Profiles………………………………………………………………….
A. Alexion Company overview, Product & Services, Strategies & Financials
B. BioMarin Company overview, Product & Services, Strategies & Financials
C. Synageva Company overview, Product & Services, Strategies & Financials
D. Amicus Company overview, Product & Services, Strategies & Financials
E. Genzyme Company overview, Product & Services, Strategies & Financials
F. Audentes Company overview, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape……………………………………
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth…………………………………………………………
A. New Trends and Development of Lysosomal Storage Disorders Therapeutics Market
B. Future Opportunities
10. Conclusion

Market Segmentation

By Treatment Type:

Based on the treatment, the lysosomal storage disorders therapeutics market can be bifurcated into

  • Enzyme Replacement Therapy
  • Stem Cell Therapy
  • Substrate Reduction Therapy
  • Other Therapies

Enzyme replacement therapy is a treatment that replaces an enzyme that is absent or deficient in the body. Some of the available enzyme replacement therapies for lysosomal storage disorders are Sebelipase Alfa, Velaglucerase Alfa, Taliglucerase Alfa, Agalsidase beta, Laronidase, and Imiglucerase among others.

The enzyme replacement therapy segment holds a significant market share in the lysosomal storage disorders therapeutics market and is anticipated to show a similar trend over the forecast period due to improving organ function and effective in reducing toxic storage material in patients suffering from lysosomal disorders.

By End Users:

In terms of end-users, the lysosomal storage disorders therapeutics market can be categorized into

  • Hospitals
  • Clinics
  • Diagnostic Centres
  • Academic and Research Organisations
  • Others

In terms of value, the hospitals’ segment accounted for the leading market share in 2020, which is attributable to the fact that the effective diagnosis and medications for LSD treatment can be only administered in the hospitals under the surveillance of trained medical professionals. Hence, the hospitals’ segment has been further anticipated to enhance the market share over the forecast period.

Top Major Players

The UK lysosomal storage disorders therapeutics market is a highly competitive market and major key players are adopting strategies; organic as well as inorganic market strategies. Kanuma by Alexion Pharmaceuticals Inc. is indicated for long-term enzyme replacement therapy (ERT) in patients of all ages for the treatment of LSD. The other prominent key players prevailing in the LSD therapeutics market are BioMarin Pharmaceuticals Inc., Synageva Biopharma Corporation, Amicus Therapeutics Inc., Genzyme Corporation, and Audentes Therapeutics Inc. among others.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.



    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements